BCTX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Briacell Therapeutics Corp (BCTX) is not a strong buy for a beginner, long-term investor at this time. The technical indicators are bearish, with the stock trading below key moving averages and a lack of positive momentum. Options data shows no significant activity or sentiment, and there are no recent news or catalysts driving the stock. Additionally, the financial performance shows weak fundamentals with negative net income and declining EPS. Given the user's preference for long-term investment and the lack of strong signals or positive trends, holding off on this stock is recommended.
The stock shows bearish technical indicators. The MACD is positive but contracting, RSI is neutral at 31.572, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 4.065), with resistance at R1: 4.438. The overall trend suggests weakness.
NULL identified. No recent news, no significant insider or hedge fund activity, and no congress trading data.
The stock has a bearish trend, with a 60% chance of further declines in the short term (-1.46% next day, -1.28% next week, -1.83% next month). Financial performance is weak, with negative net income and declining EPS.
In Q1 2026, revenue remained at 0 with no growth. Net income improved by 41.28% YoY but remains negative at -8,197,565. EPS dropped significantly by -86.69% YoY to -4.35. Gross margin is 0, indicating no profitability.
No analyst rating or price target data available for evaluation.
